Home
Conditions
Intestinal Neoplasms

Clinical trial condition

Intestinal Neoplasms

Explore clinical trials studying Intestinal Neoplasms. Study availability and eligibility vary by location and protocol.

6,346 public trials 1,367 recruiting studies

Refine in advanced search Browse all conditions

Intestinal Neoplasms trial results

Active, Not Recruiting

Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis

NCT04157322

Conditions: Appendiceal Neoplasms, Appendix Cancer, Cecal Diseases, +15 more
Locations: The University of Chicago Chicago, Illinois, United States

View Trial Details

Active, Not Recruiting

A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors

NCT03432806

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
Locations: Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Commack Commack, New York, United States

Memorial Sloan Kettering Westchester Harrison, New York, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

The Efficacy and Safety of Neoadjuvant Therapy With Iparomlimab and Tuvonralimab in Locally Advanced MSI-H/dMMR Colorectal Cancer: An Prospective, Single-Arm Study (Neo-IT)

NCT07160647

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

View Trial Details

Active, Not Recruiting

Clinical Study on the Safety and Relationship of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma

NCT07127497

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations: The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China

View Trial Details

Active, Not Recruiting

Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients

NCT03829462

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Centre Antoine Lacassagne Nice, Alpes-Maritimes, France

Centre François Baclesse Caen, Basse-Normandie, France

Hôpital Pontchaillou Rennes, Ile Et Vilaine, France

Hôpital Robert Debré Reims, Marne, France

View Trial Details

Active, Not Recruiting

Fluorescent Approach for Refined Endoscopic Marking With Clip Localization and Identification Procedure

NCT06714292

Conditions: Colon Cancer, Colonic Diseases, Colonic Neoplasms, +9 more
Locations: National Cancer Center Goyang-si, Gyeonggi-do, South Korea

Seoul National University Hospital Seoul, South Korea

Seoul Boramae Medical Center Seoul, South Korea

View Trial Details

Active, Not Recruiting

ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer

NCT06328738

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +13 more
Locations: BRCR Medical Center Inc. Plantation, Florida, United States

Washington University St Louis, Missouri, United States

NEXT Virginia Fairfax, Virginia, United States

Cliniques Universitaires Saint-Luc Brussels, Belgium

View all 31 locations

View Trial Details

Active, Not Recruiting

A Phase II/III Study of HR070803 in Combination With Oxaliplatin, 5-fluorouracil, Calcium Folinate and Bevacizumab Versus FOLFOX in Combination With Bevacizumab for First-line Treatment of Advanced Colorectal Cancer

NCT05945901

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations: Sun Yat-Sen University Cancer Center Guangzhou, Guangdog, China

View Trial Details

Active, Not Recruiting

Colon Neoadjuvant FOLFOXIRI Study

NCT01941641

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: Department of Clinical Oncology Hong Kong

View Trial Details

Active, Not Recruiting

A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China

NCT06640049

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: GSK Investigational Site Chengdu, China

GSK Investigational Site Chongqing, China

GSK Investigational Site Guangzhou, China

GSK Investigational Site Guangzhou, China

View Trial Details

Intestinal Neoplasms

Intestinal Neoplasms trial results

Related conditions